In Silico Proficiency Testing for Clinical Next-Generation Sequencing

Slides:



Advertisements
Similar presentations
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.
Advertisements

Nine Novel Germline Gene Variants in the RET Proto-Oncogene Identified in Twelve Unrelated Cases Syed A. Ahmed, Karen Snow-Bailey, W. Edward Highsmith,
CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next- Generation Sequencing Data  David H. Spencer, Haley J. Abel, Christina.
Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue Specimens  David H. Spencer, Jennifer K. Sehn,
Development of a Next-Generation Sequencing Method for BRCA Mutation Screening  Maurice Chan, Shen Mo Ji, Zhen Xuan Yeo, Linda Gan, Eric Yap, Yoon Sim.
Assessment of Target Enrichment Platforms Using Massively Parallel Sequencing for the Mutation Detection for Congenital Muscular Dystrophy  C. Alexander.
Statistical Considerations for Immunohistochemistry Panel Development after Gene Expression Profiling of Human Cancers  Rebecca A. Betensky, Catherine.
Simultaneous Detection of Clinically Relevant Mutations and Amplifications for Routine Cancer Pathology  Marlous Hoogstraat, John W.J. Hinrichs, Nicolle.
Haley J. Abel, Hussam Al-Kateb, Catherine E. Cottrell, Andrew J
Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next- Generation Sequencing Data  David H. Spencer, Haley J. Abel, Christina.
Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses  Narasimhan Nagan, Nicole E. Faulkner,
The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients
Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario  Ricardo.
Performance of Common Analysis Methods for Detecting Low-Frequency Single Nucleotide Variants in Targeted Next-Generation Sequence Data  David H. Spencer,
Diagnostic Application of an Extensive Gene Panel for Leber Congenital Amaurosis with Severe Genetic Heterogeneity  Moon-Woo Seong, Soo Hyun Seo, Young.
Cystic Fibrosis The Journal of Molecular Diagnostics
Molecular Genetics of Pediatric Soft Tissue Tumors
Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential Thrombocythemia  Fabrice Usseglio, Nathalie Beaufils, Anne Calleja, Sophie.
Mutation Screening in Juvenile Polyposis Syndrome
Joanna Wang, Chetan Bettegowda  The Journal of Molecular Diagnostics 
Maxim B. Freidin, Neesa Bhudia, Eric Lim, Andrew G
Simultaneous Detection of Clinically Relevant Mutations and Amplifications for Routine Cancer Pathology  Marlous Hoogstraat, John W.J. Hinrichs, Nicolle.
Molecular Diagnosis of Autosomal Dominant Polycystic Kidney Disease Using Next- Generation Sequencing  Adrian Y. Tan, Alber Michaeel, Genyan Liu, Olivier.
Utilization of Whole-Exome Next-Generation Sequencing Variant Read Frequency for Detection of Lesion-Specific, Somatic Loss of Heterozygosity in a Neurofibromatosis.
Ken B. Waites, Li Xiao, Vanya Paralanov, Rose M. Viscardi, John I
Gene Scanning of an Internalin B Gene Fragment Using High-Resolution Melting Curve Analysis as a Tool for Rapid Typing of Listeria monocytogenes  Ariane.
Patrick R. Murray  The Journal of Molecular Diagnostics 
Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer  Daniel Trujillano, Maximilian.
William L. Gerald, M.D., Ph.D, 1954–2008
Catherine E. Cottrell, Hussam Al-Kateb, Andrew J. Bredemeyer, Eric J
Development of a Next-Generation Sequencing Method for BRCA Mutation Screening  Maurice Chan, Shen Mo Ji, Zhen Xuan Yeo, Linda Gan, Eric Yap, Yoon Sim.
Hilmi Ozcelik, Xuejiang Shi, Martin C
Jamal H. Carter, Samantha N. McNulty, Patrick J. Cimino, Catherine E
Utility of NIST Whole-Genome Reference Materials for the Technical Validation of a Multigene Next-Generation Sequencing Test  Bennett O.V. Shum, Ilya.
Development and Validation of a Template-Independent Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated Variants of Hepatitis.
A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients  Stephen.
BRAF Mutation Testing in Solid Tumors
Multiplex Bead Suspension Array for Screening Neisseria gonorrhoeae Antibiotic Resistance Genetic Determinants in Noncultured Clinical Samples  Sergey.
The Molecular Pathology of Primary Immunodeficiencies
Iris Schrijver, Tiffanee J. Lenzi, Carol D. Jones, Marla J
Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer–Related Single-Nucleotide Variants.
Deamination Effects in Formalin-Fixed, Paraffin-Embedded Tissue Samples in the Era of Precision Medicine  Seokhwi Kim, Charny Park, Yongick Ji, Deok G.
Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next- Generation Sequencing Panel Testing  Wenbo Mu, Hsiao-Mei Lu, Jefferey.
Jennifer A. Hempelmann, Sheena M. Scroggins, Colin C
Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next- Generation Sequencing Bioinformatics and Variant Interpretation  Kurtis.
Sarah E. Kerr, Cheryl B. Thomas, Stephen N. Thibodeau, Matthew J
Rondell P. Graham, Michelle A. Dina, Sarah C. Howe, Malinda L
Genomic Technologies and the New Era of Genomic Medicine
A Clinically Validated Diagnostic Second-Generation Sequencing Assay for Detection of Hereditary BRCA1 and BRCA2 Mutations  Ian E. Bosdet, T. Roderick.
Rapid and Sensitive Real-Time Polymerase Chain Reaction Method for Detection and Quantification of 3243A>G Mitochondrial Point Mutation  Rinki Singh,
Ayalew Tefferi, Pierre Noel, Curtis A. Hanson 
Quality Assurance of RNA Expression Profiling in Clinical Laboratories
Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma  Soo-Ryum Yang, Chieh-Yu Lin, Henning Stehr, Steven.
Dale Muzzey, Shera Kash, Jillian I. Johnson, Laura M
Erratum The American Journal of Human Genetics
Validation for Clinical Use of, and Initial Clinical Experience with, a Novel Approach to Population-Based Carrier Screening using High-Throughput, Next-Generation.
Inherited Cardiomyopathies
Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas  Qiulu Pan, William Pao, Marc.
Statistical Treatment of Fluorescence in Situ Hybridization Validation Data to Generate Normal Reference Ranges Using Excel Functions  Allison L. Ciolino,
Karen Snow-Bailey, Ph.D., 1961–2006
Varying Mutational Alterations in Multiple Primary Melanomas
Nathan D. Montgomery, Sara R. Selitsky, Nirali M. Patel, D
Establishment of a Molecular Diagnostic System for Spinal Muscular Atrophy  Jian Zeng, Yanhong Lin, Aizhen Yan, Longfeng Ke, Zhongyong Zhu, Fenghua Lan 
Angiotensin I-Converting Enzyme
Monique A. Johnson, Marvin J. Yoshitomi, C. Sue Richards 
Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF  Alois H. Lang, Heinz Drexel, Simone Geller-Rhomberg,
The History and Impact of Molecular Coding Changes on Coverage and Reimbursement of Molecular Diagnostic Tests  Susan J. Hsiao, Mahesh M. Mansukhani,
Development of a Novel Next-Generation Sequencing Assay for Carrier Screening in Old Order Amish and Mennonite Populations of Pennsylvania  Erin L. Crowgey,
Presentation transcript:

In Silico Proficiency Testing for Clinical Next-Generation Sequencing Eric J. Duncavage, Haley J. Abel, John D. Pfeifer  The Journal of Molecular Diagnostics  Volume 19, Issue 1, Pages 35-42 (January 2017) DOI: 10.1016/j.jmoldx.2016.09.005 Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Generation of in silico proficiency testing (PT) sequence files. Two basic methods exist for the generation of in silico PT. A: In the simulated or de novo method, a mutation (red text) is introduced into the gene of interest by altering the corresponding position in the reference sequence. Reads are then simulated from the mutated reference sequence using estimated error rate and coverage models. Although simple to implement, such approaches may not accurately simulate the true error rate and may produce coverage distributions that do not accurately reflect real clinical data. B: Mutations can also be simulated by introducing variants into actual sequence reads from clinical cases. Using this approach, software tools modify the individual reads from aligned data to include the mutation and associated base quality score in a given fraction of reads to simulate the wanted variant allele frequencies. Alignment data are then stripped from the mutated reads, allowing for regeneration of raw sequencing files. Although more technically complex, the major advantage of this method is that it accurately simulates expected coverages and error profiles (maroon text). The Journal of Molecular Diagnostics 2017 19, 35-42DOI: (10.1016/j.jmoldx.2016.09.005) Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions